Cargando…

Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers

Objective. The present systematic review of RA registry data was undertaken to analyse the time on treatment of licensed TNF inhibitors in patients with RA in Europe. Methods. English language European registry studies comparing TNF inhibitors were searched using MEDLINE, Embase, Cochrane, and WHO:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arora, Anamika, Mahajan, Anadi, Spurden, Dean, Boyd, Helen, Porter, Duncan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838831/ https://www.ncbi.nlm.nih.gov/pubmed/24307903 http://dx.doi.org/10.1155/2013/764518

Ejemplares similares

Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register
por: Cagnotto, Giovanni, et al.
Publicado: (2020)

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
por: Orme, Michelle E, et al.
Publicado: (2012)

Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers
por: Rundquist, Sara, et al.
Publicado: (2020)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register
por: Stephansson, Olof, et al.
Publicado: (2011)

Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies
por: Linder, Marie, et al.
Publicado: (2014)

Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study
por: Hovstadius, Bo, et al.
Publicado: (2011)

Time-varying risks of infection in patients as they proceed through the phases of ‘pre-RA’: results from the Scottish Early RA inception cohort
por: Porter, Duncan, et al.
Publicado: (2023)

Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
por: Manders, Sofie H M, et al.
Publicado: (2015)

TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
por: Calvo Alén, Jaime, et al.
Publicado: (2022)

National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA
por: Ravela, Reko, et al.
Publicado: (2022)

An open science pathway for drug marketing authorization—Registered drug approval
por: Naudet, Florian, et al.
Publicado: (2021)

Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
por: von Linstow, Christian Ulrich, et al.
Publicado: (2021)

Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs
por: Zhao, Ting, et al.
Publicado: (2022)

Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis
por: Barcina Lacosta, Teresa, et al.
Publicado: (2022)

Use of prescription benzodiazepines and related drugs in family caregivers: a nation-wide register-based study
por: Mikkola, Tuija M, et al.
Publicado: (2022)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
por: Kwok, Seung-Ki
Publicado: (2014)

EHPnet: European Pollutant Emission Register
por: Dooley, Erin E.
Publicado: (2004)

Of snarks, boojums and national drug charts
por: Barber, Nick, et al.
Publicado: (2013)

TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes
por: Dai, Fang-fang, et al.
Publicado: (2022)

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2021)

Predictive Value of Conjointly Examined IL-1ra, TNF-R I, TNF-R II, and RANTES in Patients with Primary Glomerulonephritis
por: Zwiech, Rafał
Publicado: (2013)

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
por: Eleuteri, C., et al.
Publicado: (2017)

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
por: Dixon, W G, et al.
Publicado: (2009)

The impact on colorectal cancer survival of cases registered by 'death certificate only': implications for national survival rates.
por: Pollock, A. M., et al.
Publicado: (1994)

Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry
por: Studenic, Paul, et al.
Publicado: (2022)

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)

Drug induced differential gene expression in normal and RA synovial fibroblasts cell lines
por: Yahyawi, M, et al.
Publicado: (2004)

Registering New Drugs for Low-Income Countries: The African Challenge
por: Moran, Mary, et al.
Publicado: (2011)

Potential drug interactions with statins: Estonian register-based study
por: Gavronski, Maia, et al.
Publicado: (2015)

Aim and Design of pREGnant, the Dutch Pregnancy Drug Register
por: Vorstenbosch, Saskia, et al.
Publicado: (2018)

Registered Drug Packs of Antimicrobials and Treatment Guidelines for Prostatitis: Are They in Accordance?
por: Jerkovic, Ivan, et al.
Publicado: (2022)

An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
por: Patel, Rajan N., et al.
Publicado: (2020)

Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs
por: Ratner, Pamela A, et al.
Publicado: (2010)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vvor34j6l6l2jgh61k9sr2ran6